Article Versions Notes

Yamada T, Saito T, Shimizu Y, Tsukakoshi K, Hayashi H, Mizuno H, Tsuji D, Yamamoto K, Itoh K, Toyo’oka T, et al. Anti-Idiotype DNA Aptamer Affinity Purification–High-Temperature Reversed-Phase Liquid Chromatography: A Simple, Accurate, and Selective Bioanalysis of Bevacizumab. Molecules. 2019; 24(5):857. https://doi.org/10.3390/molecules24050857

Yamada, Tomohiro, Taro Saito, Yutaka Shimizu, Kaori Tsukakoshi, Hideki Hayashi, Hajime Mizuno, Daiki Tsuji, Keisuke Yamamoto, Kunihiko Itoh, Toshimasa Toyo’oka, and et al. 2019. "Anti-Idiotype DNA Aptamer Affinity Purification–High-Temperature Reversed-Phase Liquid Chromatography: A Simple, Accurate, and Selective Bioanalysis of Bevacizumab" Molecules 24, no. 5: 857. https://doi.org/10.3390/molecules24050857

Yamada, T., Saito, T., Shimizu, Y., Tsukakoshi, K., Hayashi, H., Mizuno, H., Tsuji, D., Yamamoto, K., Itoh, K., Toyo’oka, T., Ikebukuro, K., & Todoroki, K. (2019). Anti-Idiotype DNA Aptamer Affinity Purification–High-Temperature Reversed-Phase Liquid Chromatography: A Simple, Accurate, and Selective Bioanalysis of Bevacizumab. Molecules, 24(5), 857. https://doi.org/10.3390/molecules24050857